Pfizer and its German partner BioNTech said on Friday they have requested the U.S. Food and Drug Administration to expand the emergency use of their Covid-19 vaccine in adolescents aged 12 to 15. In March, the drugmakers said the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year olds in a […] Read more
Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases, with health-care workers, the elderly and people with underlying health conditions getting the first inoculations. Essential workers, teachers and people in […] Read more
